Genetic keys to COVID-19 vaccine response unlocked

A genome-wide association study in the U.K. Biobank reveals genetic factors influencing IgG serostatus against SARS-CoV-2, highlighting the role of HLA class II genes in variable immune responses to COVID-19 vaccines.

Mixed study results for MorphoSys blood-cancer drug raise questions about approval

LONDON — An experimental blood cancer drug from MorphoSys hit its primary target in a pivotal trial, the company announced late Monday, but the drug

November 21, 2023

Toxic ‘forever chemicals’ taint rural California drinking water, far from known sources

Juana Valle never imagined she’d be scared to drink water from her tap or eat fresh eggs and walnuts when she bought her 5-acre farm

December 11, 2024

High BMI affects autologous breast reconstruction outcomes

For women undergoing autologous breast reconstruction – reconstruction using the patient’s own tissues, rather than implants – the risks of overall and specific complications are

March 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.